|
|
|
Insider
Information: |
Harrington Michael J |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
156,394 |
|
Indirect Shares
|
59,952 |
|
|
Direct
Value |
$44,621,267 |
|
|
Indirect Value
|
$54,515,553 |
|
|
Total
Shares |
216,346 |
|
|
Total
Value |
$99,136,819 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
0.0
|
Percentage
Gain/Loss : |
-100.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
Senior VP and General ... |
2019-10-24 |
47,800 |
2019-10-24 |
59,952 |
Premium* |
|
Elanco Animal Health Inc |
ELAN |
|
2024-08-22 |
81,094 |
2019-04-11 |
0 |
Premium* |
|
Inotiv Ord Shs |
NOTV |
Director |
2024-08-10 |
27,500 |
2024-08-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
Senior VP and General CounselO |
|
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
376 |
|
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General CounselO |
|
2013-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,568 |
|
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2013-01-25 |
4 |
A |
$53.21 |
$300,051 |
D/D |
5,639 |
21,207 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2014-01-28 |
4 |
A |
$54.23 |
$520,879 |
D/D |
9,605 |
30,812 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2014-08-12 |
4 |
D |
$61.08 |
$151,601 |
D/D |
(2,482) |
31,052 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2014-08-12 |
4 |
OE |
$55.65 |
$151,479 |
D/D |
2,722 |
32,293 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2015-01-28 |
4 |
A |
$70.97 |
$529,862 |
D/D |
7,466 |
38,518 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2015-04-28 |
4 |
OE |
$56.18 |
$338,428 |
D/D |
6,024 |
44,542 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2015-04-28 |
4 |
D |
$70.89 |
$367,494 |
D/D |
(5,184) |
39,358 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2015-11-25 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,276 |
37,082 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2016-01-26 |
4 |
A |
$81.96 |
$1,472,084 |
D/D |
17,961 |
55,043 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,066 |
64,109 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2016-02-01 |
4 |
D |
$79.10 |
$331,745 |
D/D |
(4,194) |
59,915 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2017-01-27 |
4 |
A |
$75.38 |
$1,604,463 |
D/D |
21,285 |
79,700 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,732 |
89,432 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2017-02-01 |
4 |
D |
$77.03 |
$349,947 |
D/D |
(4,543) |
84,889 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2017-06-09 |
4 |
AS |
$79.97 |
$1,825,955 |
D/D |
(22,833) |
62,056 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2018-01-29 |
4 |
A |
$87.60 |
$1,415,441 |
D/D |
16,158 |
78,214 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,524 |
102,738 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2018-02-01 |
4 |
D |
$81.45 |
$880,556 |
D/D |
(10,811) |
91,927 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2019-02-01 |
4 |
D |
$119.86 |
$527,863 |
D/D |
(4,404) |
98,144 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,778 |
102,548 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2019-02-04 |
4 |
A |
$120.17 |
$3,383,386 |
D/D |
28,155 |
126,299 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2019-02-04 |
4/A |
A |
$120.17 |
$3,383,507 |
D/D |
28,156 |
126,300 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Senior VP and General Counsel |
|
2019-02-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
62,500 |
62,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|